Focuses on a predictive marker survival of lymphoma patients with O&sup6;-methylguanine DNA methyltransferase (MGMT). Association between MGMT expression and resistance to cyclophosphamide; Correlation between MGMT levels in ovarian carcinomas and patient survival; Impact of MMT on sensitivity to cyclophosphamide.